Buy Semaglutide 20 mg (GLP1-S) | Pure Lab Peptides Supply
GLP1-S 20 mg: Semaglutide Research Material
Buy Semaglutide 20 mg (GLP1-S) from Pure Lab Peptides Supply for laboratory research and analytical applications. This product is supplied as lyophilized powder in one boxed 3 mL vial.
Semaglutide is a synthetic peptide studied in research involving glucagon-like peptide-1 (GLP-1) receptor signaling. Its molecular modifications distinguish it from native GLP-1 and related peptide analogues. Therefore, researchers should review the compound information and relevant analytical records before selecting material for a particular study.
The 20 mg label identifies the stated material quantity. Meanwhile, the 3 mL measurement describes the vial’s container capacity, not a supplied liquid volume or solution concentration.
Product Overview
GLP1-S 20 mg is a single-compound semaglutide research-material listing. It offers a higher labeled material quantity than the 5 mg and 10 mg presentations. However, the larger quantity does not automatically establish higher purity or different analytical characteristics.
- Product Name: GLP1-S (Semaglutide)
- Labeled Quantity: 20 mg
- Presentation: One boxed 3 mL vial
- Physical Format: Lyophilized powder
- Compound Class: Synthetic GLP-1 analogue peptide
- Reference Sequence Length: 31 amino acids
- Product Type: Single-compound research material
- Intended Application: Laboratory research, analytical characterization, and in-vitro assay development
- CAS Number: 910463-68-2, as listed for the semaglutide reference compound
- Reference Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
- Reference Molecular Weight: Approximately 4,114 g/mol
- Supplier-Listed Purity: ≥99%; verify the applicable batch documentation
- Documentation: Review the available COA and product documentation
The molecular formula and weight refer to the listed reference molecule. However, they do not independently establish the complete chemical form of the supplied material. Therefore, verify any salt, counterion, or additional formulation details before using reference values in analytical calculations.
Compare the Available GLP1-S Presentations
Pure Lab Peptides Supply lists GLP1-S in different labeled quantities, including 5 mg, 10 mg, and 20 mg. Each presentation provides a different stated material amount. Consequently, choose the quantity that matches your planned laboratory requirements.
The 20 mg presentation provides twice the labeled amount of the 10 mg option. Nevertheless, this difference does not establish a change in molecular identity, purity, or research properties. In addition, review the product records associated with the exact presentation you select.
Single-Compound Material Versus a Blend
GLP1-S 20 mg represents the single-compound semaglutide listing. By contrast, a cagrilintide and GLP1-S blend contains two separate components.
For that reason, distinguish the total milligram quantity of a blend from the amount assigned to each compound. Always check the product-specific composition before comparing listings or recording material quantities in research documentation.
Explore the available catalog at Pure Lab Peptides Supply.
Semaglutide Research Background
GLP-1 Receptor Research
Researchers study semaglutide in experimental work involving GLP-1 receptor signaling. These investigations examine molecular characteristics and receptor-related endpoints under defined laboratory conditions.
However, published findings apply to the materials and methods used in each study. They do not independently confirm the identity, purity, or performance of a commercial batch. Therefore, evaluate product documentation separately from published scientific evidence.
Molecular Modifications and Compound Characterization
Semaglutide contains structural modifications that distinguish it from native GLP-1. Consequently, researchers comparing related peptides should examine the reference structure and confirm the identity of the specific material under investigation.
Analytical characterization also involves several distinct measurements. For example, compound identity helps establish what material a test examines. Chromatographic purity describes the distribution of detected components under the analytical method. Meanwhile, measured content addresses the quantity determined by the relevant procedure.
These measurements answer different questions. As a result, researchers should evaluate them separately rather than treating one purity figure as complete evidence of every product attribute.
In-Vitro Assays and Analytical Method Development
Semaglutide research may involve controlled in-vitro assays, compound characterization, and analytical method development. Nevertheless, experimental findings depend on the assay design, analytical method, and material under examination.
A published study therefore provides scientific context rather than automatic confirmation of a commercial vial. Before comparing results, verify that the documented compound identity and analytical methods suit the planned investigation.
Product Specifications
- CAS Number: 910463-68-2, as listed for the reference compound
- Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉, as listed for the reference molecule
- Molecular Weight: Approximately 4,114 g/mol, as listed for the reference molecule
- Purity: Supplier-listed specification of ≥99%; check the applicable batch report
- Appearance: White lyophilized powder
- Synthesis Method: Solid-phase synthesis, according to the supplied product specifications
- Solubility: Water or 1% acetic acid, according to the supplied product specifications; verify compatibility with the intended laboratory method
- Stability and Storage: The supplied specifications state a storage period of up to 24 months at −20°C. Confirm the applicable expiry and storage requirements against the product records.
- Shipping Conditions: The supplied specifications state shipment at ambient temperature, followed by storage at −20°C after receipt. Follow the current product-specific handling instructions.
- Regulatory and Compliance Information: The supplied product information states that the manufacturer operates in a facility that adheres to cGMP guidelines. Request supporting documentation when verification matters to your research.
- Safety Information: Consult the applicable material safety data sheet (MSDS) or current safety documentation.
These specifications reflect the information supplied for this product family. However, general product details cannot replace batch-specific evidence. In particular, the reference formula and molecular weight do not independently confirm the exact chemical form or complete composition of an individual vial.
COA and Product Documentation
Review Available Batch Records
Before relying on an analytical result, match the certificate of analysis (COA) to the exact product, presentation, and lot under consideration. You can begin with the COA and product documentation page.
Where available, review the reported identity, chromatographic purity, measured content, analytical method, and testing date. Moreover, examine the report itself to understand which sample and measurements it covers.
A report for another presentation or batch does not automatically apply to GLP1-S 20 mg. Similarly, a supplier’s general purity specification does not replace the findings in the relevant analytical report.
GLP1-S 20 mg Certificate of Analysis
Batch-specific documentation should identify the tested sample and connect the reported results to the correct product lot. Therefore, review the applicable COA before relying on any analytical result.
The previously supplied GLP1-S 10 mg report refers to a different labeled presentation and must not automatically serve as the certificate for the 20 mg listing. Confirm the 20 mg lot number, report number, testing date, and measured results before adding those details to this page.
Storage and Laboratory Handling
Follow the product-specific technical documentation when determining suitable storage and handling conditions. Although the supplied product specifications state storage at −20°C for up to 24 months, verify the applicable expiry information before relying on that period.
Additionally, distinguish the stability of the original lyophilized material from the stability of a prepared solution. The original material’s storage information does not automatically establish prepared-solution stability. Likewise, a general solubility statement does not confirm compatibility with every solvent, buffer, or analytical procedure.
Before handling the material, review the relevant safety documentation and follow appropriate laboratory procedures. Keep the product records available for traceability throughout the research process.
Frequently Asked Questions
What is GLP1-S 20 mg?
GLP1-S 20 mg is the catalog listing for semaglutide research material. The product description specifies lyophilized powder in one boxed 3 mL vial, with a labeled material quantity of 20 mg.
Is GLP1-S the same as semaglutide?
The supplied catalog information identifies GLP1-S as semaglutide. Nevertheless, researchers should confirm the identity and chemical form of the specific material through its applicable product documentation.
What does the 20 mg quantity mean?
The 20 mg figure represents the labeled material quantity. By comparison, the 3 mL figure describes the vial’s capacity. Neither value specifies a supplied liquid volume or prepared solution concentration.
How does the 20 mg presentation compare with the 5 mg and 10 mg sizes?
The main difference is the labeled material quantity. The 20 mg listing provides a larger stated amount. However, researchers should review the documentation for the selected presentation and should not assume that a larger quantity establishes higher purity or different analytical characteristics.
What research areas involve semaglutide?
Semaglutide appears in research involving GLP-1 receptor signaling, compound characterization, and analytical methods. However, individual findings depend on the study design, experimental material, and testing conditions.
Where can I find the COA?
Visit the COA and product documentation page to review available records. For batch-specific research, match the report to the exact product presentation and lot before relying on its results.
How should GLP1-S 20 mg be stored?
The supplied product-family specifications list storage at −20°C and state a period of up to 24 months. However, consult the applicable product records for the actual expiry information and handling requirements.
Is this product intended for human or veterinary use?
No. This listing is intended for laboratory research only. It is not intended for human consumption or veterinary use.
Order GLP1-S 20 mg from Pure Lab Peptides Supply
Choose GLP1-S 20 mg (semaglutide) for laboratory research and analytical work that requires a defined labeled material quantity. Before selecting this presentation, review the specifications and confirm that the available documentation meets your research requirements.
Visit Pure Lab Peptides Supply to explore the catalog and review the available product documentation.
For laboratory research only. Not for human or veterinary use.

















